Joint transformer architecture in brain 3D MRI classification: its application in Alzheimer's disease classification.

Alzheimer’s disease MRI Sequence classification Transfer learning Vision transformer

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 Apr 2024
Historique:
received: 17 11 2023
accepted: 12 04 2024
medline: 19 4 2024
pubmed: 19 4 2024
entrez: 18 4 2024
Statut: epublish

Résumé

Alzheimer's disease (AD), a neurodegenerative disease that mostly affects the elderly, slowly impairs memory, cognition, and daily tasks. AD has long been one of the most debilitating chronic neurological disorders, affecting mostly people over 65. In this study, we investigated the use of Vision Transformer (ViT) for Magnetic Resonance Image processing in the context of AD diagnosis. ViT was utilized to extract features from MRIs, map them to a feature sequence, perform sequence modeling to maintain interdependencies, and classify features using a time series transformer. The proposed model was evaluated using ADNI T1-weighted MRIs for binary and multiclass classification. Two data collections, Complete 1Yr 1.5T and Complete 3Yr 3T, from the ADNI database were used for training and testing. A random split approach was used, allocating 60% for training and 20% for testing and validation, resulting in sample sizes of (211, 70, 70) and (1378, 458, 458), respectively. The performance of our proposed model was compared to various deep learning models, including CNN with BiL-STM and ViT with Bi-LSTM. The suggested technique diagnoses AD with high accuracy (99.048% for binary and 99.014% for multiclass classification), precision, recall, and F-score. Our proposed method offers researchers an approach to more efficient early clinical diagnosis and interventions.

Identifiants

pubmed: 38637671
doi: 10.1038/s41598-024-59578-3
pii: 10.1038/s41598-024-59578-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8996

Subventions

Organisme : National Institutes of Health,United States
ID : R01HL145753, R01HL145753-01S1, R01HL145753-03S1
Organisme : National Institutes of Health,United States
ID : P20GM121307, R01HL149264

Informations de copyright

© 2024. The Author(s).

Références

Artif Intell Med. 2022 Aug;130:102332
pubmed: 35809971
Comput Biol Med. 2022 Aug;147:105737
pubmed: 35785662
Artif Intell Med. 2016 Jul;71:1-29
pubmed: 27506128
J Magn Reson Imaging. 2008 Apr;27(4):685-91
pubmed: 18302232
Comput Biol Med. 2022 Feb;141:105032
pubmed: 34838263
Med Image Anal. 2023 Apr;85:102762
pubmed: 36738650
Sensors (Basel). 2022 Jan 19;22(3):
pubmed: 35161486
Behav Brain Res. 2018 May 15;344:103-109
pubmed: 29454006
Alzheimers Res Ther. 2022 Dec 21;14(1):191
pubmed: 36544184
Front Neurosci. 2018 Nov 05;12:777
pubmed: 30455622
IEEE Trans Pattern Anal Mach Intell. 2020 Apr;42(4):880-893
pubmed: 30582529
Neuroimage. 2020 Mar;208:116459
pubmed: 31837471
Neuroimage. 2005 Jul 1;26(3):839-51
pubmed: 15955494

Auteurs

Sait Alp (S)

Department of Computer Engineering, Erzurum Technical University, Erzurum, Turkey.

Taymaz Akan (T)

Division of Clinical Informatics, Department of Medicine, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Center for Brain Health, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.

Md Shenuarin Bhuiyan (MS)

Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.

Elizabeth A Disbrow (EA)

Center for Brain Health, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Department of Pharmacology, Toxicology and Neuroscience, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Department of Neurology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Department of Psychiatry, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.

Steven A Conrad (SA)

Division of Clinical Informatics, Department of Medicine, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Department of Pediatrics, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.

John A Vanchiere (JA)

Department of Pharmacology, Toxicology and Neuroscience, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Department of Pediatrics, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.

Christopher G Kevil (CG)

Department of Pathology and Translational Pathobiology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.
Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA.

Mohammad A N Bhuiyan (MAN)

Division of Clinical Informatics, Department of Medicine, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA. Nobel.Bhuiyan@lsuhs.edu.
Center for Brain Health, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103-4228, USA. Nobel.Bhuiyan@lsuhs.edu.

Classifications MeSH